REFERENCE
European Medicines Agency.European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix. Media Release: 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Questions and answers on the review of Zerit (stavudine): outcome of a renewal procedure. Internet Document: [2 pages], 17 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Restrictions on use of Zerit. Internet Document: [1 page], 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Restrictions on use of Tygacil. Internet Document: [1 page], 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Questions and answers on the review of Tygacil (tigecycline): outcome of a renewal procedure. Internet Document: [2 pages], 17 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.New contraindication for Brinavess. Internet Document: [1 page], 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Review of buflomedil-containing medicines started. Internet Document: [1 page], 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
European Medicines Agency.Review of pholcodine-containing medicines started. Internet Document: [1 page], 18 Feb 2011. Available from: URL: http://www.ema.europa.eu
Rights and permissions
About this article
Cite this article
Pandemrix linked to narcolepsy says EMA’s CHMP. React. Wkly. 1340, 4 (2011). https://doi.org/10.2165/00128415-201113400-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113400-00008